TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Encompass Health ( (EHC) ) is now available.
Encompass Health has announced that it does not provide guidance on a GAAP basis for certain financial measures due to the unpredictable nature of items outside the company’s control, such as legal settlements and restructuring costs. The company has, however, provided estimable GAAP measures for 2025, including interest expenses and amortization of debt-related items, which will be included in a reconciliation for Adjusted EBITDA.
The most recent analyst rating on (EHC) stock is a Hold with a $124.00 price target. To see the full list of analyst forecasts on Encompass Health stock, see the EHC Stock Forecast page.
Spark’s Take on EHC Stock
According to Spark, TipRanks’ AI Analyst, EHC is a Neutral.
Encompass Health’s overall stock score reflects strong financial performance and positive earnings call sentiment, offset by technical analysis indicating bearish momentum and valuation concerns. The company’s strategic growth initiatives and increased guidance are positive, but cash flow management and valuation metrics warrant caution.
To see Spark’s full report on EHC stock, click here.
More about Encompass Health
Average Trading Volume: 713,868
Technical Sentiment Signal: Buy
Current Market Cap: $11.69B
Learn more about EHC stock on TipRanks’ Stock Analysis page.